Add to cart
Up to 43% OFF

Broad Spectrum CBD Distillate

Price range: $25.21 through $265.99Earn up to 532 points.

-43%

Our sale. Prices go up again at midnight Eastern.

Broad-spectrum CBD distillate — CBD with the minor cannabinoids and no detectable Delta 9. The base for tinctures and topicals that want more than isolate.

COA and batch date on every jar. Ships from Colorado to every state except CO.

Free shipping over $129 after codes.

What the research says about CBD (cannabidiol): Strongest evidence base of any cannabinoid: randomized trials of purified CBD (Epidiolex) in two rare epilepsies led to FDA approval in 2018 (Devinsky 2017, NEJM: 39% median seizure reduction vs 13% placebo in Dravet syndrome). Read the studies →
Published research, summarised for education — not medical advice.

See the lab results (COAs) for our products →

Placeholder
Broad Spectrum CBD Distillate $25.21 – $265.99Price range: $25.21 through $265.99Earn up to 532 points.
or
Lab tested, COA for every batch on request. Questions before you buy? Text me at 424-666-5929. — Bret
  • Laboratory Tested for Quality, Purity & Label Integrity
  • No GMOs, No Fillers, No Pollutants
  • Thousands of Happy Customer Reviews
  • A payment to vivimu.com will appear on your statement

Questions? Text 210-401-8521. A real person helps fast.

Lab tested. Ships with tracking. Text us anytime: 210-401-8521.

Buying 1 kg or more? Text (210) 401-8521 for a bulk quote.

Price per gram — bigger jar, lower per gram
28 grams$24.96$0.89/g—
100 grams$73.87$0.74/gsave 17%
500 grams$265.99$0.53/gsave 40%

Broad Spectrum CBD Distillate — CBD-rich distillate with the minor cannabinoids and terpenes retained, non-detect THC. Lab tested by lot.

Lab Results (COA) — batch CBDBS-091626.1, Kaycha Labs, sampled 09/22/26

Additional information

size: No selection

3.5 grams, 7 grams, 14 grams, 28 grams, 56 grams, 100 grams, 250 grams, 500 grams, 1000 grams

CBD (cannabidiol) — what the research says

The most-studied non-intoxicating cannabinoid. Sold here as 99% isolate (crystalline powder) and in broad-spectrum distillate.

How it interacts with receptors. Very low direct affinity for CB1/CB2; acts as a negative allosteric modulator of CB1, a 5-HT1A serotonin-receptor agonist, a TRPV1 agonist and an inhibitor of FAAH (the enzyme that breaks down anandamide).

What human research reports. Strongest evidence base of any cannabinoid: randomized trials of purified CBD (Epidiolex) in two rare epilepsies led to FDA approval in 2018 (Devinsky 2017, NEJM: 39% median seizure reduction vs 13% placebo in Dravet syndrome). A double-blind study found a single 600 mg dose reduced anxiety measures during a simulated public-speaking test in people with social anxiety (Bergamaschi 2011). A 2019 case series (72 psychiatric-clinic patients) reported anxiety scores fell in 79% during the first month; sleep scores were less consistent (Shannon 2019).

Animal and cell research. Hundreds of animal and cell studies on inflammation, seizure models, pain models and neuroprotection; most human-relevant conclusions still come from the epilepsy trials.

Sources

  1. Devinsky O, et al. Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome. N Engl J Med 2017;376:2011-20.
  2. Bergamaschi MM, et al. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients. Neuropsychopharmacology 2011;36:1219-26.
  3. Shannon S, et al. Cannabidiol in anxiety and sleep: a large case series. Perm J 2019;23:18-041.
  4. Laprairie RB, et al. Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor. Br J Pharmacol 2015;172:4790-805.

Published research, summarised for education — not medical advice. Full library and blend builder: vivimu.com/cannabinoid-research/cbd

Related products